FIGURE

Fig. 8

ID

ZDB-FIG-240419-57

Publication

Li et al., 2024 - A natural small molecule aspidosperma-type alkaloid, hecubine, as a new TREM2 activator for alleviating lipopolysaccharide-induced neuroinflammation in vitro and in vivo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 8

Blockade of Nrf2 abolished the anti-inflammatory effect of Hecubine. BV2 cells were treated with Hecubine in the presence or absence of LPS after transient transfection of Nrf2 siRNA and control siRNA. The protein levels of Nrf2 (a), HO-1 (b), TLR4, and MyD88 (c) were determined by Western blotting (n = 3). The production of TNF-α, IL-6, and NO (d) was measured via Griess reagent and an ELISA assay, respectively (n = 3). The mRNA levels of iNOS, TNF-α (e), IL-6, and IL-1β (f) were detected by qPCR analysis (n = 4). The data from the experiments are expressed as the mean ± SD of three independent experiments. *p < 0.05 vs. LPS-treated group; #p < 0.05 vs. control; One-way ANOVA with Dunnett’s multiple comparisons test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Redox Biol.